Pediatrix Medical Group, Inc. Comprehensive Income
Pediatrix Medical Group, Inc. (MD) reported Comprehensive Income of $39.38 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-04
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $39.38M, a 0.78% decline year-over-year.
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $29.04M, a 34.96% increase year-over-year.
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $33.85M, a 14.28% increase year-over-year.
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $72.02M, a 239.93% increase year-over-year.
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $167.07M.
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$97.93M.
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$58.89M, a 196.09% decline from fiscal 2022.
- Pediatrix Medical Group, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $61.28M, a 52.40% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $39.38M 10-Q · filed 2026-08-04 | $68.42M 10-Q · filed 2026-08-04 | $102.27M derived: sum of 3 quarters · filed 2026-08-04 | $174.28M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $29.04M 10-Q · filed 2026-05-05 | $62.89M derived: sum of 2 quarters · filed 2026-05-05 | $134.90M derived: sum of 3 quarters · filed 2026-05-05 | $174.59M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $33.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $105.86M derived: sum of 2 quarters · filed 2026-02-19 | $145.55M derived: sum of 3 quarters · filed 2026-08-04 | $167.07M 10-K · filed 2026-02-19 |
| 2025-09-30 | $72.02M 10-Q · filed 2025-11-03 | $111.71M derived: sum of 2 quarters · filed 2026-08-04 | $133.22M 10-Q · filed 2025-11-03 | $162.84M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $39.69M 10-Q · filed 2026-08-04 | $61.20M 10-Q · filed 2026-08-04 | $90.82M derived: sum of 3 quarters · filed 2026-08-04 | $112.01M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $21.52M 10-Q · filed 2026-05-05 | $51.13M derived: sum of 2 quarters · filed 2026-05-05 | $72.32M derived: sum of 3 quarters · filed 2026-05-05 | -$80.50M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $29.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $50.80M derived: sum of 2 quarters · filed 2026-02-19 | -$102.02M derived: sum of 3 quarters · filed 2026-02-19 | -$97.93M 10-K · filed 2026-02-19 |
| 2024-09-30 | $21.19M 10-Q · filed 2025-11-03 | -$131.64M derived: sum of 2 quarters · filed 2025-11-03 | -$127.54M 10-Q · filed 2025-11-03 | -$250.53M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$152.82M 10-Q · filed 2025-08-05 | -$148.73M 10-Q · filed 2025-08-05 | -$271.71M derived: sum of 3 quarters · filed 2026-02-19 | -$250.32M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $4.09M 10-Q · filed 2025-05-06 | -$118.89M derived: sum of 2 quarters · filed 2026-02-19 | -$97.50M derived: sum of 3 quarters · filed 2026-02-19 | -$69.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$122.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$101.59M derived: sum of 2 quarters · filed 2026-02-19 | -$73.70M derived: sum of 3 quarters · filed 2026-02-19 | -$58.89M 10-K · filed 2026-02-19 |
| 2023-09-30 | $21.39M 10-Q · filed 2024-11-01 | $49.29M derived: sum of 2 quarters · filed 2024-11-01 | $64.10M 10-Q · filed 2024-11-01 | $94.12M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $27.89M 10-Q · filed 2024-08-06 | $42.70M 10-Q · filed 2024-08-06 | $72.73M derived: sum of 3 quarters · filed 2025-02-20 | $101.94M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-03-31 | $14.81M 10-Q · filed 2024-05-07 | $44.84M derived: sum of 2 quarters · filed 2025-02-20 | $74.05M derived: sum of 3 quarters · filed 2025-02-20 | $99.95M derived: sum of 4 quarters · filed 2025-02-20 |
| 2022-12-31 | $30.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $59.24M derived: sum of 2 quarters · filed 2025-02-20 | $85.14M derived: sum of 3 quarters · filed 2025-02-20 | $61.28M 10-K · filed 2025-02-20 |
| 2022-09-30 | $29.21M 10-Q · filed 2023-11-02 | $55.12M derived: sum of 2 quarters · filed 2023-11-02 | $31.26M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $25.90M 10-Q · filed 2023-08-03 | $2.05M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$23.86M 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | $128.75M 10-K · filed 2024-02-20 | |||
| 2020-12-31 | -$793.04M 10-K · filed 2023-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |